Global Cluster Headaches Market Size, Trends & Growth Opportunity, By Drug Type (Triptans, Octreotide, Opioids, and Others), By Drug Application (Abortive, Transitional, and Preventive), and By Product Type (Calcium Channel Blockers, Corticosteroids, Lithium Carbonate, Ergots, Melatonin, Anti-Seizure, and Local Anesthetics), By Region and Forecast till 2030
Global Cluster Headaches Market
Cluster headache is a type of neurological disorder that is characterized by severe headaches recurring on one side of the head usually around the eye. This is accompanied by automatic symptoms like excessive tears, swelling of the eye and nasal decongestion. In cluster headaches individual often suffer from excruciating attacks of unilateral headaches.
Market Drivers
Rise in aging population is the key driving factor which is expected to boost the global cluster headaches market growth. Furthermore, increase in technological advancements and developments in healthcare industry will positively influence the market growth during this analysis period. Moreover, increase in television viewing and computer usage among population is also expected to drive the market growth. In addition to that, rise in willingness among people to spend more on healthcare treatment which is expected to fuel the market growth in near future.
Market Restraints
However, lack of awareness among healthcare provider is the major restraining factor which is expected hampers the global cluster headaches market growth. Also, unfavorable healthcare policies will obstruct the market growth.
Market Segmentation
Global Cluster Headaches Market is segmented into drug type such as Triptans, Octreotide, Opioids, and Others, by drug application such as Abortive, Transitional, and Preventive, by product type such as Calcium Channel Blockers, Corticosteroids, Lithium Carbonate, Ergots, Melatonin, Anti-Seizure, and Local Anesthetics. Further, market is segmented into End user such as Hospitals, Clinics, Retail Pharmacies and Drug Stores, and E-commerce.
Also, Global Cluster Headaches Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Market Key Players
Various key players are discussed in this report such as GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd, Novartis AG, AstraZeneca, Pfizer Inc., Fresenius Kabi, Sagent Pharmaceuticals, Inc, and Aurobindo Pharma
Market Taxonomy
By Drug Type
• Triptans
• Octreotide
• Opioids
• Others
By Application
• Abortive
• Transitional
• Preventive
By Product Types
• Calcium Channel Blockers
• Corticosteroids
• Lithium Carbonate
• Ergots
• Melatonin
• Anti-Seizure
• Local Anesthetics
By End user
• Hospitals
• Clinics
• Retail Pharmacies and Drug Stores
• E-commerce
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Cluster Headaches Market?
• What will be the growth rate from 2019 to 2030?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?
Cluster Headaches Market , Cluster Headaches Industry,Cluster Headaches Market Size,Cluster Headaches Market Share,Cluster Headaches Market Trend,Cluster Headaches Market Growth
Global Cluster Headaches Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Cluster Headaches Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Cluster Headaches Market, By Drug Type
5.1 Y-o-Y Growth Comparison, By Drug Type
5.2 Global Cluster Headaches Market Share Analysis, By Drug Type
5.3 Global Cluster Headaches Market Size and Forecast, By Drug Type
5.3.1 Triptans
5.3.2 Octreotide
5.3.3. Opioids
5.3.4. Others
6 Global Cluster Headaches Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Cluster Headaches Market Share Analysis, By Application
6.3 Global Cluster Headaches Market Size and Forecast, By Application
6.3.1 Abortive
6.3.2 Transitional
6.3.3 Preventive
7 Global Cluster Headaches Market, By Product Type
7.1 Y-o-Y Growth Comparison, By Product Type
7.2 Global Cluster Headaches Market Share Analysis, By Product Type
7.3 Global Cluster Headaches Market Size and Forecast, By Product Type
7.3.1 Calcium Channel Blockers
7.3.2. Corticosteroids
7.3.3. Lithium Carbonate
7.3.4. Ergots
7.3.5. Melatonin
7.3.6. Anti- Seizure
7.3.7. Local Anaesthetics
8 Global Cluster Headaches Market, By End User
8.1 Y-o-Y Growth Comparison, By End User
8.2 Global Cluster Headaches Market Share Analysis, By End User
8.3 Global Cluster Headaches Market Size and Forecast, By End User
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Retail Pharmacies & Drug Stores
8.3.4. E-Commerce
9Global Cluster Headaches Market, By Region
9.1 Global Cluster Headaches Market Share Analysis, By Region
9.2 Global Cluster Headaches Market Share Analysis, By Region
9.3 Global Cluster Headaches Market Size and Forecast, By Region
10 North America Cluster Headaches Analysis and Forecast (2019 – 2030)
10.1 Introduction
10.2 North America Cluster Headaches Market Share Analysis, By Drug Type
10.3 North America Cluster Headaches Market Size and Forecast, By Application
10.4 North America Cluster Headaches Market Size and Forecast, By Product Type
10.5 North America Cluster Headaches Market Size and Forecast, By End User
10.6 North America Cluster Headaches Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11Europe Cluster Headaches Market Analysis and Forecast (2019 – 2030)
11.1 Introduction
11.2 Europe Cluster Headaches Market Share Analysis, By Drug Type
11.3 Europe Cluster Headaches Market Size and Forecast, By Application
11.4 Europe Cluster Headaches Market Size and Forecast, By Product Type
11.5 Europe Cluster Headaches Market Size and Forecast, By End User
11.6 Europe Cluster Headaches Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.64. Rest of Europe
12Asia Pacific Cluster Headaches Market Analysis and Forecast (2019 – 2030)
12.1 Introduction
12.2 Asia Pacific Cluster Headaches Market Share Analysis, By Drug Type
12.3 Asia Pacific Cluster Headaches Market Size and Forecast, By Application
12.4 Asia Pacific Cluster Headaches Market Size and Forecast, By Product Type
12.5 Asia Pacific Cluster Headaches Market Size and Forecast, By End User
12.6 Asia Pacific Cluster Headaches Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific
13Latin America Cluster Headaches Market Analysis and Forecast (2019 – 2030)
13.1 Introduction
13.2 Latin America Cluster Headaches Market Share Analysis, By Drug Type
13.3 Latin America Cluster Headaches Market Size and Forecast, By Application
13.4 Latin America Cluster Headaches Market Size and Forecast, By Product Type
13.5 Latin America Cluster Headaches Market Size and Forecast, By End User
13.6 Latin America Cluster Headaches Market Size and Forecast, By Country
14Middle East Cluster Headaches Market Analysis and Forecast (2019 – 2030)
14.1 Introduction
14.2 Middle East Cluster Headaches Market Share Analysis, By Drug Type
14.3 Middle East Cluster Headaches Market Size and Forecast, By Application
14.4 Middle East Cluster Headaches Market Size and Forecast, By Product Type
14.5 Middle East Cluster Headaches Market Size and Forecast, By End User
14.6 Middle East Cluster Headaches Market Size and Forecast, By Country
15Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16Company Profiles
16.1 GlaxoSmithKline plc
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Eli Lilly and Company
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Teva Pharmaceutical Industries Ltd
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Novartis AG
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 AstraZeneca
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Pfizer Inc
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7 Fresenius Kabi
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Sagent Pharmaceuticals, Inc
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Aurobindo Pharma
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
